Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple…
canadian psychedelics stocks
One billion shares No matter what FSD Pharma (HUGE.N) does, I will always remember them as the company that bragged endlessly about having more than a billion shares outstanding….
Diverse clinics Ketamine One (MEDI.NE) announced it’s adding 2 more locations to its already bustling ketamine clinic network. Through an acquisition last week, Ketamine One gains control of Illumma…
Mainstream adoption I was 19 rows back, dead center as Roger Waters played Comfortably Numb next to 80-foot Pink Floyd stage props. The MDMA had kicked in long ago,…
Jamaica, farewell At first glance, I didn’t know what to make of Aion Therapeutics (AION.C). There are a few moving parts, it’s a psychedelics/cannabis hybrid deal with a focus…
Doubling down on Cybin Back in January, Horizons’ (PYSK.NE) ETF held a relatively balanced portfolio of psychedelics companies. No company made up more than 10% of its holdings, with…
Everyone who went near a cannabis stock has probably seen or heard of Bruce Linton. He was a charismatic guy who rarely wore more than a t-shirt and jeans….
Magnifying the problem When lockdowns first hit back in March 2020 I was pretty sure the capital markets and the psychedelic sector would suffer. It was a burgeoning…
“The cardinal rule is to keep them playing and to keep them coming back. The longer they play, the more they lose, and in the end, we get it…
Speed Before the widespread fear-mongering in Western media and culture around LSD it was becoming rather popular in the psychiatry community in both North America and Europe. In the…